SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals - Quaterly Results

13 Feb 2024 Evaluate
The revenue for the December 2023 quarter is pegged at Rs. 588.00 millions against Rs. 590.20 millions recorded during the year-ago period.Net Profit recorded in the quarter ended December 2023 rise to 33.07% to Rs. 50.70  millions  compared to R. 38.10 millions in corresponding previous quarter.Operating profit surged to 91.80 millions from the corresponding previous quarter of 74.50 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 588.00 590.20 -0.37 1885.20 1670.10 12.88 2179.80 2120.10 2.82
Other Income 24.00 39.50 -39.24 87.10 118.80 -26.68 188.40 77.80 142.16
PBIDT 91.80 74.50 23.22 334.10 266.50 25.37 402.10 360.00 11.69
Interest 6.10 7.90 -22.78 21.00 13.80 52.17 21.90 9.70 125.77
PBDT 85.70 66.60 28.68 313.10 252.70 23.90 380.20 350.30 8.54
Depreciation 16.70 14.30 16.78 47.90 44.20 8.37 58.50 66.60 -12.16
PBT 69.00 52.30 31.93 265.20 208.50 27.19 321.70 283.70 13.39
TAX 18.30 14.20 28.87 70.00 58.00 20.69 78.30 70.70 10.75
Deferred Tax -3.90 0.70 -657.14 -0.60 1.60 -137.50 -5.70 -9.40 -39.36
PAT 50.70 38.10 33.07 195.20 150.50 29.70 243.40 213.00 14.27
Equity 57.75 57.75 0.00 58.20 57.75 0.78 57.70 57.70 0.00
PBIDTM(%) 15.61 12.62 23.68 17.72 15.96 11.06 18.45 16.98 8.64

Bharat Parenterals Share Price

1213.10 32.30 (2.74%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×